| Literature DB >> 24396460 |
Zhien Feng1, Han-Guang Zhu2, Li Zhen Wang3, Jia-Wei Zheng2, Wan-Tao Chen2, Zhiyuan Zhang2, Wei Dong4, Weiguo Qu4, Yan An Wang2.
Abstract
Tricholemmal carcinoma is an extremely rare malignancy of the skin, and its biological behavior and management is controversial. The objective of the present study was to investigate the clinicopathological characteristics and management of tricholemmal carcinoma of the head and neck region. The study analyzed 15 patients with tricholemmal carcinoma. Demographic and clinical data were collected, and features associated with the management and prognosis of tricholemmal carcinoma were analyzed. Two of the 15 patients were lost to follow-up. The results showed that, during the follow-up period, 5 of the 13 available patients succumbed to the causes of recurrence (n=3), neck lymph node metastasis (n=1) and Parkinson's disease (n=1). No patients developed distant metastasis. The disease-free survival (DFS) and overall survival (OS) were 31.1±7.8 and 32.9±7.4 months (mean ± SE), respectively, and the DFS and OS rates were 69.2 and 61.5%, respectively. In conclusion, the biological behavior of tricholemmal carcinoma is locoregionally aggressive. The recommended management for head and neck tricholemmal carcinoma is radical resection and neck dissection, and post-operative radiotherapy may be considered for high-risk patients.Entities:
Keywords: clinicopathological features; head and neck; prognosis; treatment; tricholemmal carcinoma
Year: 2013 PMID: 24396460 PMCID: PMC3881694 DOI: 10.3892/ol.2013.1726
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967
Clinical observations of 15 patients with tricholemmal carcinoma of the head and neck region.
| Case no. | Gender/age, years | Site | Longest diameter, cm | Recurrence | LN metastasis | Prognosis |
|---|---|---|---|---|---|---|
| 1 | F/78 | Nose | 1.5 | No | Yes | Mortality |
| 2 | F/88 | Temple | 5.0 | No | No | Mortality |
| 3 | F/24 | Face | 3.0 | No | No | Survival |
| 4 | F/83 | Bilateral face | 3.5 | Yes | No | Mortality |
| 5 | F/91 | Face | 6.0 | No | Yes | Survival |
| 6 | M/87 | Face | 1.0 | No | No | Survival |
| 7 | M/69 | Bilateral temple | 13.0 | Yes | No | Mortality |
| 8 | F/83 | Temple | 2.0 | No | No | Survival |
| 9 | M/81 | Face | 5.0 | No | Yes | Survival |
| 10 | F/90 | Face | 3.0 | Yes | No | Mortality |
| 11 | F/92 | Face | 2.5 | No | No | Survival |
| 12 | M/66 | Face | 3.0 | Missing | Missing | Lost to follow-up |
| 13 | F/81 | Face | 3.0 | No | No | Survival |
| 14 | F/57 | Face (multiple lesions) | 2.0 | Missing | Missing | Lost to follow-up |
| 15 | F/92 | Face | 2.0 | No | No | Survival |
Neck LN metastasis was apparent at diagnosis;
cause of mortality was Parkinson’s disease.
LN, lymph node; F, female; M, male.
Figure 1Typical histopathological appearance of head and neck tricholemmal carcinoma. (A) HE stain, (B) P-CK stain and (C) KRT15 stain. Magnification, left image ×200 and right image ×400. HE, hematoxylin and eosin; P-CK, pan-cytokeratin; KRT15, keratin 15.
Figure 2Clinical signs and treatment of a giant tricholemmal carcinoma with recurrence/multiple lesions. (A) Pre-operative image showing a giant lesion on the right temple. (B) Pre-operative image showing lesions on the left temple. (C) Pre-operative computed tomography image in the coronal plane. (D) Intraoperative image showing the appearance following radical resection of the lesions. (E) Post-operative image of the right-sided lesion taken 1 week later. (F) Post-operative image of the left-sided lesions taken 1 week later.